Filing Details
- Accession Number:
- 0000899243-22-011326
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-03-16 20:55:14
- Reporting Period:
- 2022-03-12
- Accepted Time:
- 2022-03-16 20:55:14
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1501134 | Invitae Corp | NVTA | Services-Medical Laboratories (8071) | 271701898 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1695496 | Thomas Brida | C/O Invitae Corporation 1400 16Th Street San Francisco CA 94103 | General Counsel | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2022-03-12 | 14,705 | $0.00 | 247,726 | No | 4 | A | Direct | |
Common Stock | Disposition | 2022-03-14 | 17,987 | $6.69 | 229,739 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | A | Direct | |
No | 4 | S | Direct |
Footnotes
- Shares issued upon settlement of a restricted stock unit award that vests in two equal installments, with 1/2 of the remaining award vesting on March 12, 2023, subject to continued service with the issuer through such vesting date.
- Includes 484 shares of common stock acquired under the Invitae Corporation Employee Stock Purchase Plan on November 12, 2021 and an aggregate of 91,486 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.
- Represents the sale of shares to cover tax withholding obligations associated with the vesting and settlement of restricted stock units.
- Represents a weighted average sale price. Actual sale prices ranged from $6.6868 to $6.6876 per share. The reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated.